Mettler-Toledo International, Inc. $MTD Stock Sold by Candriam S.C.A.

Candriam S.C.A. lessened its position in shares of Mettler-Toledo International, Inc. (NYSE:MTD) by 83.4% during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 3,668 shares of the medical instruments supplier’s stock after selling 18,369 shares during the period. Candriam S.C.A.’s holdings in Mettler-Toledo International were worth $5,562,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors and hedge funds have also bought and sold shares of the company. BlackRock Inc. bought a new position in Mettler-Toledo International in the 2nd quarter valued at $2,404,713,000. Bank of New York Mellon Corp purchased a new position in shares of Mettler-Toledo International during the 2nd quarter valued at $762,553,000. Wellington Management Group LLP increased its holdings in shares of Mettler-Toledo International by 908.6% in the second quarter. Wellington Management Group LLP now owns 459,064 shares of the medical instruments supplier’s stock worth $586,459,000 after purchasing an additional 413,547 shares during the period. Amundi increased its holdings in shares of Mettler-Toledo International by 40.7% in the second quarter. Amundi now owns 240,640 shares of the medical instruments supplier’s stock worth $307,420,000 after purchasing an additional 69,620 shares during the period. Finally, Bank of America Corp DE raised its position in shares of Mettler-Toledo International by 60.9% in the first quarter. Bank of America Corp DE now owns 207,286 shares of the medical instruments supplier’s stock worth $261,429,000 after buying an additional 78,487 shares in the last quarter. 95.07% of the stock is currently owned by hedge funds and other institutional investors.

Mettler-Toledo International News Roundup

Here are the key news stories impacting Mettler-Toledo International this week:

• Positive Sentiment: Barclays raised its target from $1,700 to $1,900 and maintained an overweight rating; Stifel lifted its target from $1,600 to $1,900 and assigned a buy rating. Both targets imply further upside from the reference share price of $1,749.74. Barclays price target article Stifel price target article
• Neutral Sentiment: Robert W. Baird raised its target from $1,608 to $1,815 but kept a neutral rating. JPMorgan also retained a neutral rating despite lifting its target from $1,550 to $1,725. Goldman Sachs raised its target from $1,510 to $1,640, still below the reference share price—signaling that analyst views remain divided. Baird price target article Goldman Sachs price target article
• Negative Sentiment: Insider Gerry Keller sold 435 shares for about $754,000, reducing his direct holding by 62.68% to 259 shares. Insider sales can weigh on sentiment, though the filing alone does not indicate the reason for the transaction. SEC insider transaction filing

Analyst Ratings Changes

Several equities research analysts recently issued reports on MTD shares. Stifel Nicolaus lifted their price objective on Mettler-Toledo International from $1,600.00 to $1,900.00 and gave the company a “buy” rating in a research note on Monday. UBS Group began coverage on Mettler-Toledo International in a research note on Wednesday, September 9th. They issued a “neutral” rating and a $1,460.00 target price on the stock. Jefferies Financial Group raised their price target on Mettler-Toledo International from $1,400.00 to $1,580.00 and gave the company a “buy” rating in a report on Friday, July 31st. Morgan Stanley lifted their price target on Mettler-Toledo International from $1,450.00 to $1,575.00 and gave the company an “equal weight” rating in a research report on Tuesday, October 13th. Finally, JPMorgan Chase & Co. lifted their price target on Mettler-Toledo International from $1,550.00 to $1,725.00 and gave the company a “neutral” rating in a research report on Monday. Six investment analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, Mettler-Toledo International has an average rating of “Hold” and an average target price of $1,595.77.

Insiders Place Their Bets

In other Mettler-Toledo International news, insider Gerry Keller sold 435 shares of the firm’s stock in a transaction dated Monday, November 9th. The stock was sold at an average price of $1,734.05, for a total transaction of $754,311.75. Following the sale, the insider owned 259 shares in the company, valued at $449,118.95. This trade represents a 62.68% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CEO Patrick Kaltenbach sold 942 shares of the firm’s stock in a transaction dated Thursday, August 27th. The shares were sold at an average price of $1,425.00, for a total value of $1,342,350.00. Following the sale, the chief executive officer owned 4,480 shares in the company, valued at $6,384,000. The trade was a 17.37% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. 0.71% of the stock is owned by corporate insiders.

Mettler-Toledo International Price Performance

Shares of NYSE:MTD opened at $1,749.74 on Wednesday. The company’s fifty day moving average price is $1,538.82 and its 200-day moving average price is $1,349.09. The firm has a market capitalization of $34.80 billion, a price-to-earnings ratio of 37.91, a PEG ratio of 3.52 and a beta of 1.16. Mettler-Toledo International, Inc. has a one year low of $1,023.05 and a one year high of $1,806.58. The company has a debt-to-equity ratio of 25.28, a current ratio of 1.10 and a quick ratio of 0.75.

Mettler-Toledo International (NYSE:MTD) last posted its quarterly earnings data on Thursday, November 5th. The medical instruments supplier reported $12.57 earnings per share for the quarter, beating the consensus estimate of $12.13 by $0.44. Mettler-Toledo International had a net margin of 22.25% and a return on equity of 15,012.71%. The firm had revenue of $1.09 billion for the quarter, compared to analysts’ expectations of $1.07 billion. During the same quarter last year, the company posted $11.15 EPS. The business’s quarterly revenue was up 6.3% on a year-over-year basis. On average, equities research analysts anticipate that Mettler-Toledo International, Inc. will post 47.83 earnings per share for the current fiscal year.

About Mettler-Toledo International

Mettler-Toledo International develops and manufactures precision instruments and systems used in laboratory, industrial, and retail settings. Its products include laboratory balances and analytical instruments, industrial scales and weighing systems, and equipment for measuring and monitoring production processes. The company also supplies product-inspection systems, including checkweighers, metal detectors, and X-ray inspection equipment, along with related software, installation, maintenance, and calibration services.